06 Mar 2023|Noida
| Amity University, Noida
Amity Scientist develops highly active ‘Novel Protease Enzyme’,
Transfers Technology to industry for further usage
The Directorate of Innovation and Technology Transfer (DITT), Amity University Uttar Pradesh, signed a Technology Transfer (TT) Agreement with M/s Balaji Advance Enzymes & Chemicals Pvt. Ltd., a Maharashtra based Start-Up Company, to license the highly active, ‘Novel Protease Enzyme’, developed by Dr. Nidhee Chaudhary, Professor, Amity Institute of Biotechnology and her team. Through this Agreement, the innovation will be transferred to M/s Balaji Advance Enzymes & Chemicals Pvt. Ltd., which will further supply it to other industries including food and beverages industry, nutraceuticals, leather industry, meat industry, diagnostics, detergent industry, pharmaceutical industry and other industries. The company is one of the leading manufacturers of Aliphatic Amines in India, was set up in the year 1988 to cater to the growing requirements of value-based Specialty Chemicals.
Talking about her innovation, ‘Novel Protease Enzyme’, Dr. Nidhee Chaudhary, Professor, Amity Institute of Biotechnology, said, “Proteases are a group of enzymes that break the long chain- like molecules of proteins into shorter fragments and eventually into their components, amino acids. The global protease market size was valued at $3,454.3 million in 2020 and is projected to reach $5,762.7 million by 2030. Ginger is the source of Proteases and proteases are used in food and beverages industry, nutraceuticals, leather industry, detergent industry, pharmaceutical industry and cosmetics industry, to name a few. Since the “Novel Protease Enzyme” is highly active, upto 8 times more, it will help in reduction of the cost of manufacturing products, thereby helping the common man.”
Speaking on the occasion, Mr. Abhay Kainya, Founder & Director, Balaji Advance Enzymes & Chemicals Pvt. Ltd., said, “We are extremely delighted to sign the Technology Transfer Agreement with Amity University which marks the beginning of our collaboration in the field of research and innovation. Through this Agreement, we aim to commercialize the innovation so that it successfully reaches the masses.”
Expressing his extreme delight on this occasion, Dr. Ashok K. Chauhan, Founder President, Amity Education Group, stated, “It is a matter of immense pleasure and pride that Amity scientists are constantly working on path-breaking innovations, and it is heartening to see the outcome of these researches in the form of such collaborations. This is not just a Technology Transfer Agreement, but it is a testimony to Amity’s commitment to contribute to the scientific development of the country, through young researchers and innovators.”
Addressing the gathering, Dr. Balvinder Shukla, Vice Chancellor, Amity University Uttar Pradesh, said, “Technology Transfer is not easy since industries are not very receptive to new technologies and innovations. It requires a lot of hard work and risk-taking abilities from both sides, the innovator as well as the industry, to accept new technologies and bring it to a fruitful conclusion. Therefore, Amity University is extremely pleased at this remarkable achievement of its Scientists who have made it possible and created a significant impact on the industry. “
Also present on the occasion were Dr. W. Selvamurthy, President, Amity Science Technology and Innovation Foundation, Dr. B. C. Das, Chairman & Chair Professor, Amity Institute of Molecular Medicine and Stem Cell Research, Dr. Dilip J. Upadhyay, Vice President, Amity Foundation for Science Technology and Innovation Alliance, Dr. A. Chakraborty, Registrar (Officiating) Amity University Uttar Pradesh and Dr. Meenakshi Kanojia, Deputy Director, Directorate of Innovation and Technology Transfer (DITT) and the MoU Signing Ceremony concluded with the felicitation of the guests.